Mostrar el registro sencillo del ítem
dc.contributor.author
Gagliardino, Juan Jose
dc.contributor.author
Elgart, Jorge Federico
dc.contributor.author
Forti, Luján
dc.contributor.author
Querzoli, Ivanna
dc.contributor.author
Chantelot, Jean Marc
dc.date.available
2021-01-12T13:53:57Z
dc.date.issued
2019-07
dc.identifier.citation
Gagliardino, Juan Jose; Elgart, Jorge Federico; Forti, Luján; Querzoli, Ivanna; Chantelot, Jean Marc; Type 2 diabetes: Prescription patterns and treatment outcomes of IDMPS survey in Argentina; Elsevier Ireland; Diabetes Research and Clinical Practice; 153; 7-2019; 86-92
dc.identifier.issn
0168-8227
dc.identifier.uri
http://hdl.handle.net/11336/122469
dc.description.abstract
Aim To assess prescription patterns for treatment of type 2 diabetes (T2D) and their outcomes in the IDMPS survey in Argentina. Methods Data from 2551 people with T2D recruited from 210 physicians participating in IDMPS surveys in Argentina (2006 to 2012 waves) were recorded, including medical history, medications, glycemic control, blood pressure, and lipid status. Results Most people were treated with oral glucose-lowering drugs (OGLDs) (65%), followed by combinations of these drugs plus insulin (22%) and only insulin (13%). These percentages varied according to T2D duration, the frequency of OGLDs decreasing while contrastingly and only insulin increasing (under 5 years versus over 10 years of disease duration, respectively). Average systolic blood pressure (SBP), HbA1c and LDL-c were significantly higher in patients treated with insulin either alone or associated with OGLDs. The percentage of people at target values for these parameters was also lower in these two groups. The percentage of people that reached simultaneous goal treatment values for BP, HbA1c and LDL-c levels was markedly low. Conclusion Prescription patterns for treatment of T2D follows a chronological trend and the percentage of people at goal values (HbA1c, BP and LDL-c values) was significantly lower in people receiving insulin. These data must be carefully considered by health and academic authorities in order to implement effective strategies to modify this situation.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier Ireland
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
COMBINED TREATMENT GOALS
dc.subject
HBA1C AND INSULIN TREATMENT
dc.subject
PRESCRIPTION STYLE
dc.subject
QUALITY OF CARE
dc.subject
TREATMENT GOALS ATTAINMENT
dc.subject.classification
Políticas y Servicios de Salud
dc.subject.classification
Ciencias de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Type 2 diabetes: Prescription patterns and treatment outcomes of IDMPS survey in Argentina
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2020-11-20T17:15:21Z
dc.journal.volume
153
dc.journal.pagination
86-92
dc.journal.pais
Irlanda
dc.description.fil
Fil: Gagliardino, Juan Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Endocrinología Experimental y Aplicada. Universidad Nacional de La Plata. Facultad de Ciencias Médicas. Centro de Endocrinología Experimental y Aplicada; Argentina
dc.description.fil
Fil: Elgart, Jorge Federico. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Endocrinología Experimental y Aplicada. Universidad Nacional de La Plata. Facultad de Ciencias Médicas. Centro de Endocrinología Experimental y Aplicada; Argentina
dc.description.fil
Fil: Forti, Luján. Sanofi Aventis Argentina Sociedad Anonima.; Argentina
dc.description.fil
Fil: Querzoli, Ivanna. Sanofi Aventis Argentina Sociedad Anonima.; Argentina
dc.description.fil
Fil: Chantelot, Jean Marc. Sanofi; Francia
dc.journal.title
Diabetes Research and Clinical Practice
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.diabres.2019.05.008
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(18)31768-6/fulltext
Archivos asociados